AIDS-defining cancers in Western Europe, 1994-2001

AIDS Patient Care and STDs

Volumn 18, Issue 9, 2004, Pages 501-508

  Ebrahim, Shahul H ^a   Abdullah, A S M ^b   McKenna, Mathew ^a   Hamers, Francoise F ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c INSTITUT DE VEILLE SANITAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AIDS DEFINING CANCER; ARTICLE; BISEXUALITY; CANCER; EPIDEMIOLOGICAL DATA; FEMALE; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; WESTERN EUROPE;

EID: 4944260150     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2004.18.501     Document Type: Article

References (18)

1. Morten F, Biggar RJ, Engels EA, et al. Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285;1736-1745.
2. Mbulaiteye SM, Bigger RJ, Goedert JJ, Engels EA. Immunodeficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 2003;32:527-33.
3. Selik MR, Byers RH, Dworkin MS. Trends in diseases reported on US death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 2002;29:378-387.
4. Corey C, Redman M, Huang ML, Pauk J, Lampinen T, Hawes S. HIV infection and human herpesvirs-8 oral shedding among men who have sex with men. J AIDS 2004;35:233-238.
5. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus infected adults. J Natl Cancer Inst 2000;92:1823-30.
6. Heard I, Tassie J-M, Kazatchkine MD, Orth G. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive. AIDS 2002;16:1799-802.
7. Maiman M, Fruchter RG, Clark M, et al. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1997;89:76-80
8. Hamers FF, Infuso A, Alix J, Downs AM. Current situation and regional perspective of HIV/AIDS surveillance in Europe. J Acquir Immune Defic Syndr 2003;32:S39-48.
9. Semaille C, Downs AM, Hamers FF. European HIV/AIDS case reporting: Assessing past treatment history in persons who develop AIDS in the era of HAART. AIDS 2003;17:270-272.
10. Serraino D, Carrieri P, Pradier C, et al. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 1999;82:334-337.
11. Butel JS. Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000;21:404-426.
12. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW. Effect of antiretroviral therapy on recent trends in selected cancers among HIV infected persons. J Acquir Immune Defic Syndr 1999;21:S11-S17.
13. Vilchez RA, Finch CJ, Jorgensen JL, Butel JS. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active retroviral therapy (HAART) era. Medicine 2003;82:77-81.
14. Bigger RJ, Rabkin CS. The epidemiology of AIDS-related neoplasms. Hematol Oncol Clin North Am 1996;10:997-1010.
15. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Epstein-Barr virus and Kaposi sarcoma herpesvirus/human herpesvirs 8. IARC Publications, Volume 70. Lyon 1997.
16. Delmas MD, Larsen D, van Benthem B, et al. Cervical squamous intraepithelial lesions in HIV-infected women: Prevalence, incidence and regression. AIDS, 2000;14:1775-1784.
17. Franceschi S, Herrero R, La Vecchia C. Cervical cancer screening in Europe, what next? Eur J Cancer 2000;36:2272-2275.
18. Fisch M, Bigger RJ, Engels EA, Goedert JJ. Association of cancer with AIDS related immunsuppression in adults. JAMA 2001;245:1736-1745.